CSF-1

Treatment for Presbyopia FDA Accepts Orasis Pharmaceuticals’ New Drug Application for CSF-1 for the Treatment of Presbyopia Investigational, novel eye drop candidate was assigned PDUFA

Read more
VP-102

Treatment for Molluscum Contagiosum Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum Potential First FDA-approved Therapy for

Read more